PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

MOZZ Research - First Half 2021, page-10

  1. 1,099 Posts.
    lightbulb Created with Sketch. 818
    Outstanding doesn't even come close to describing the value of Mozz's contribution.
    The intel is far superior to what is available on any other public forum.
    Many thanks from this investor....
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.